Epoetin alfa is a recombinant form of human erythropoietin, an erythropoiesis-stimulating agent utilized to treat anemia associated with chronic kidney disease, chemotherapy, or zidovudine therapy for… Read more
Epoetin alfa is a recombinant form of human erythropoietin, an erythropoiesis-stimulating agent utilized to treat anemia associated with chronic kidney disease, chemotherapy, or zidovudine therapy for HIV. This category offers high-quality reference standards for the active pharmaceutical ingredient, alongside a comprehensive selection of pharmacopeial and non-pharmacopeial impurities. Laboratories rely on these materials for critical analytical testing, impurity profiling, and rigorous method validation to ensure the therapeutic consistency of the biologic. The inclusion of stable isotope labelled compounds facilitates precise quantification and tracking within complex matrices, supporting essential quality control procedures. By providing access to these specialized derivatives, researchers and analytical chemists can maintain strict compliance with regulatory standards during the development and stability testing of Epoetin alfa formulations.